Ultimovacs ASA: Invitation to first quarter 2024 results webcast presentation
GlobeNewswire
*Oslo, April 30, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing..
*Oslo, April 30, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing..
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Global Cord Blood Corporation..
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Nanobiotechnology - Global Strategic Business Report" report has been added to *..